DRUG · Mapped RxNorm record
Filgrastim
Normalized identity: filgrastim View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
NCT00002126
Study summary
ClinicalTrials.govA Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
HIV Infectionsunresolved
Cytopeniasunresolved
Interventions
FilgrastimDRUG · verified · RxNorm: filgrastim
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
TorontoOntario, Canada3BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1San AntonioTexas, United States1San FranciscoCalifornia, United States1ClevelandOhio, United States1BirminghamAlabama, United States1PortlandOregon, United States1MontrealQuebec, Canada1Washington D.C.District of Columbia, United States1PhoenixArizona, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002126 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.